Clinical Trial Update: Renal Effects of Intrarenal Nesiritide [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating renal effects of intrarenal nesiritide in heart failure patients; the study was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Nesiritide (recombinant human B-type natriuretic peptide (rhBNP))

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Heart Failure, Congestive | Phase 4 | Status: TERMINATED